CMO Regis Technologies opens potent API site

By Fiona BARRY

- Last updated on GMT

Regis employees received training in handling dangerous chemicals
Regis employees received training in handling dangerous chemicals

Related tags Pharmacology

Regis Technologies has opened a site for manufacturing highly potent active pharmaceutical ingredients (HPAPIs) in Illinois.

The contract manufacturing organisation invested in a potent compound suite at its 36,000 sq ft cGMP site in Morton Grove, Illinois. The suite will produce potent compounds up to 1kg per batch for small molecule oncology drugs and linker payloads for antibody drug conjugates.

Construction and training of eleven staff in HPAPI handling took two years. Working with dangerous compounds means learning to use ventilated balance enclosures, containment isolators, a fog shower, and personal protective equipment.

The company said instead of choosing outside hires to lead the potent compound suite, it advertised for the position internally and used Safebridge Consultants to train supervisors.

Chemists must read more than 20 Standard Operating Procedures (SOPs) related to potent compound handling before beginning work in the controlled suite. SOPs for cGMP facilities are written documents which employees must follow perfectly without input from a supervisor to pass their training.

Related news

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...

Follow us

Products

View more

Webinars